Problem being addressed:
Mass scale testing is an increasing challenge as India tries to arrest the rapid spread of Covid-19. Currently all individuals, irrespective of risk profile, who have either been in contact with Covid-19 positive patient or are showing Covid-19 symptoms such as temperature, cough, body ache etc, are being tested through RT-PCR India will need a platform for mass scale screening that uses technology to triage and recommend high-risk patients for RT-PCR tests prescribe) + innovative ways to administer the test so that we can test at scale.
Qure.ai has come up with a platform called ‘qXR’ that can be an effective tool to triage and prioritize testing for the samples most likely to be positive for COVID 19 based on lung condition.The platform can also be equipped with mobile vans and booths that are used as screening tools. Out of the patients identified as high risks by qXR, almost 85% of them detected COVID-19 on the RT-PCR machine
Prashant Warrier (Co-founder, Ex-Fractal Analytics, SAP, Georgia Tech MS) and Pooja Rao (Co-founder) lead this fully operational business with a team of 40 people